Tag:

Abbott Laboratories

Latest Headlines

Latest Headlines

Abbott snags CE mark for molecular diagnostic platform for sepsis

Abbott Laboratories snagged a CE mark for its molecular diagnostic platform for blood-related infections, continuing its diagnostics winning streak and moving the company one step closer to securing stateside approval for its product.

What's in a Big Pharma name? Abbott aims to find out with international branding push

Abbott Laboratories is hitching its wagon to growth in emerging markets, rolling out an expanded branding campaign to cozy up with consumers and amp up its presence abroad.

Smith & Nephew CEO to stay, not making move to Sanofi

Rumors have been circulating in recent weeks that the French CEO of Smith & Nephew, Olivier Bohuon, would jump ship to run Paris-based Sanofi. But Bohuon told employees at a town hall meeting that he is "very happy" at Smith & Nephew, and several people with knowledge of the matter said he isn't planning to leave.

Fresenius expansion plans in Russia sidelined by political turmoil

Planning to expand its production capacity in Russia and the former Soviet Republic, Germany's Fresenius Kabi agreed this year to partner up with Binnopharm, a Moscow-based drugmaker that has two manufacturing facilities making IV drugs, infusion solutions and active pharmaceutical ingredients, not unlike Fresenius. But the political situation in Russia has made that too difficult, so Fresenius and Binnopharm are exploring other ways to work together.

Abbott seals a deal with Zeiss to sell cataract surgery products

Abbott made separate announcements related to devices focused on the eyes. The first was for a deal it reached with Carl Zeiss Meditec to sell the Swiss lensmaker's cataract surgery products alongside its own ocular surgery devices.

Abbott opens third nutrition plant this year

Abbott Laboratories, which has made a large bet on its global nutrition business, is in the final throw of a manufacturing triple play. The Chicago-area company this week opened a nutrition products plant in India after opening plants in the U.S. and China several months ago.

BrainScope among trio of med techs getting $100M from DOD

The U.S. Department of Defense has bestowed $100 million in contracts with three med tech companies. The recent awardees include Abbott Laboratories, Impact Instrumentation and BrainScope. The BrainScope grant will go to further R&D for its traumatic brain injury assessment system, while the other two were for medical equipment.

Abbott invests $60M in optics--its fastest growing device segment--with Malaysian plant

Abbott Laboratories will invest $60 million in an intraocular lens manufacturing plant in Malaysia. The plant is expected to employ about 500 people and to be operational next year, producing 1 million sets of IOLs a year.

Abbott gets $20M from DOD to develop portable concussion test

Abbott Laboratories and the United States Department of Defense are collaborating to develop a test that can be used to assess potential concussions quickly in the field. Abbott's handheld diagnostic i-Stat System is already in use by the military; the test will be developed for use on it.

Abbott's Dx arm chugs along in Q2

Abbott Laboratories reported solid sales gains in its core laboratory and point-of-care diagnostics lines during the 2014 second quarter, thanks to larger testing volumes and new products.